期刊
EXPERIMENTAL DERMATOLOGY
卷 24, 期 9, 页码 709-710出版社
WILEY
DOI: 10.1111/exd.12718
关键词
melanoma; mitochondria; oxidative phosphorylation; phenformin; resistance
类别
资金
- Amgen
- Boehringer Ingelheim
- Roche
- Bristol-Myers Squibb
- Merck
- MSD
- GlaxoSmithKline [NCT01227889]
- Novartis
- TEVA